UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 181

Sortiert nach

ESR1 mutations in breast cancer

Cancer, 2019-11, Vol.125 (21), p.3714-3728

2019

Volltextzugriff (PDF)

Role of MTA2 in human cancer

Cancer and metastasis reviews, 2014-12, Vol.33 (4), p.921-928

2014

Volltextzugriff (PDF)

Tamoxifen through GPER upregulates aromatase expression: a novel mechanism sustaining tamoxifen-resistant breast cancer cell growth

Breast cancer research and treatment, 2014-07, Vol.146 (2), p.273-285

2014

Volltextzugriff (PDF)

Androgen receptor overexpression induces tamoxifen resistance in human breast cancer cells

Breast cancer research and treatment, 2010-05, Vol.121 (1), p.1-11

2010

Volltextzugriff (PDF)

ESR1 mutations affect anti-proliferative responses to tamoxifen through enhanced cross-talk with IGF signaling

Breast cancer research and treatment, 2016-06, Vol.157 (2), p.253-265

2016

Volltextzugriff (PDF)

ESR1 mutations and therapeutic resistance in metastatic breast cancer: progress and remaining challenges

British journal of cancer, 2022-02, Vol.126 (2), p.174-186

2022

Volltextzugriff (PDF)

Estrogen Receptor Mutations in Human Disease

Endocrine reviews, 2004-12, Vol.25 (6), p.869-898

2004

Volltextzugriff (PDF)

Metastasis tumor-associated protein 2 enhances metastatic behavior and is associated with poor outcomes in estrogen receptor-negative breast cancer

Breast cancer research and treatment, 2013-10, Vol.141 (3), p.375-384

2013

Volltextzugriff (PDF)

Targeting thyroid hormone receptor beta in triple-negative breast cancer

Breast cancer research and treatment, 2015-04, Vol.150 (3), p.535-545

2015

Volltextzugriff (PDF)

Metastasis: complexity thwarts precision targeting

British journal of cancer, 2021-10, Vol.125 (8), p.1033-1035

Fuqua, Suzanne A W

2021

Volltextzugriff (PDF)

In vitro mechanism for downregulation of ER-α expression by epigallocatechin gallate in ER+/PR+ human breast cancer cells

Molecular nutrition & food research, 2013-05, Vol.57 (5), p.840-853

2013

Volltextzugriff (PDF)

Low Levels of Estrogen Receptor β Protein Predict Resistance to Tamoxifen Therapy in Breast Cancer

Clinical cancer research, 2004-11, Vol.10 (22), p.7490-7499

2004

Volltextzugriff (PDF)

Estrogen Receptor Mutations and Changes in Downstream Gene Expression and Signaling

Clinical cancer research, 2010-05, Vol.16 (10), p.2702-2708

2010

Volltextzugriff (PDF)

Breast Cancer Patients with Progesterone Receptor PR-A-Rich Tumors Have Poorer Disease-Free Survival Rates

Clinical cancer research, 2004-04, Vol.10 (8), p.2751-2760

2004

Volltextzugriff (PDF)

Targeted therapy for breast cancer and molecular mechanisms of resistance to treatment

Current opinion in pharmacology, 2016-12, Vol.31, p.97-103

2016

Volltextzugriff (PDF)

Leptin Mediates Tumor―Stromal Interactions That Promote the Invasive Growth of Breast Cancer Cells

Cancer research (Chicago, Ill.), 2012-03, Vol.72 (6), p.1416-1427

2012

Volltextzugriff (PDF)

Phosphorylation of estrogen receptor α blocks its acetylation and regulates estrogen sensitivity

Cancer research (Chicago, Ill.), 2004-12, Vol.64 (24), p.9199-9208

2004

Volltextzugriff (PDF)

Hormonal modulation of ESR1 mutant metastasis

Oncogene, 2021-02, Vol.40 (5), p.997-1011

2021

Volltextzugriff (PDF)

G Protein-Coupled Receptor 30 Expression Is Up-Regulated by EGF and TGFα in Estrogen Receptor α-Positive Cancer Cells

Molecular endocrinology (Baltimore, Md.), 2009-11, Vol.23 (11), p.1815-1826

2009

Volltextzugriff (PDF)

Metastasis-Associated Protein 2 Is a Repressor of Estrogen Receptor α Whose Overexpression Leads to Estrogen-Independent Growth of Human Breast Cancer Cells

Molecular endocrinology (Baltimore, Md.), 2006-09, Vol.20 (9), p.2020-2035

2006

Volltextzugriff (PDF)

RON signalling promotes therapeutic resistance in ESR1 mutant breast cancer

British journal of cancer, 2021-01, Vol.124 (1), p.191-206

2021

Volltextzugriff (PDF)

Evidence for diversity in transcriptional profiles of single hematopoietic stem cells

PLoS genetics, 2006-09, Vol.2 (9), p.e159-e159

2006

Volltextzugriff (PDF)

ESR1 Mutations in Cell-Free DNA of Breast Cancer: Predictive "Tip of the Iceberg"

JAMA oncology, 2016-10, Vol.2 (10), p.1315

2016

Volltextzugriff (PDF)

Association between the Estrogen Receptor α A908G Mutation and Outcomes in Invasive Breast Cancer

Clinical cancer research, 2007-06, Vol.13 (11), p.3235-3243

2007

Volltextzugriff (PDF)

hypersensitive estrogen receptor α mutation that alters dynamic protein interactions

Breast cancer research and treatment, 2010-07, Vol.122 (2), p.381-393

2010

Volltextzugriff (PDF)

1 – 25 von 181

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(178)
Mit Volltextzugriff
(164)

Publikationsform

Sprache

Englisch
(181)
Japanisch
(25)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

ESR1 mutations in breast cancer

Role of MTA2 in human cancer

Tamoxifen through GPER upregulates aromatase expression: a novel mechanism sustaining tamoxifen-resistant breast cancer cell growth

Androgen receptor overexpression induces tamoxifen resistance in human breast cancer cells

ESR1 mutations affect anti-proliferative responses to tamoxifen through enhanced cross-talk with IGF signaling

ESR1 mutations and therapeutic resistance in metastatic breast cancer: progress and remaining challenges

Estrogen Receptor Mutations in Human Disease

Metastasis tumor-associated protein 2 enhances metastatic behavior and is associated with poor outcomes in estrogen receptor-negative breast cancer

Targeting thyroid hormone receptor beta in triple-negative breast cancer

Metastasis: complexity thwarts precision targeting

In vitro mechanism for downregulation of ER-α expression by epigallocatechin gallate in ER+/PR+ human breast cancer cells

Low Levels of Estrogen Receptor β Protein Predict Resistance to Tamoxifen Therapy in Breast Cancer

Estrogen Receptor Mutations and Changes in Downstream Gene Expression and Signaling

Breast Cancer Patients with Progesterone Receptor PR-A-Rich Tumors Have Poorer Disease-Free Survival Rates

Targeted therapy for breast cancer and molecular mechanisms of resistance to treatment

Leptin Mediates Tumor―Stromal Interactions That Promote the Invasive Growth of Breast Cancer Cells

Phosphorylation of estrogen receptor α blocks its acetylation and regulates estrogen sensitivity

Hormonal modulation of ESR1 mutant metastasis

G Protein-Coupled Receptor 30 Expression Is Up-Regulated by EGF and TGFα in Estrogen Receptor α-Positive Cancer Cells

Metastasis-Associated Protein 2 Is a Repressor of Estrogen Receptor α Whose Overexpression Leads to Estrogen-Independent Growth of Human Breast Cancer Cells

RON signalling promotes therapeutic resistance in ESR1 mutant breast cancer

Evidence for diversity in transcriptional profiles of single hematopoietic stem cells

ESR1 Mutations in Cell-Free DNA of Breast Cancer: Predictive "Tip of the Iceberg"

Association between the Estrogen Receptor α A908G Mutation and Outcomes in Invasive Breast Cancer

hypersensitive estrogen receptor α mutation that alters dynamic protein interactions

Suchergebnisse filtern